The partnership will involve progressing macrophage-targeting antibody treatment for cancer [...]
Thu, Mar 23, 2023
Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance [...]
Thu, Mar 23, 2023
Study involves SFX-01 candidate and emerging preliminary pharmacokinetic data from study [...]
Wed, Mar 22, 2023
Measures include a requirement to publicly register studies and share results among research participants [...]
Wed, Mar 22, 2023

 

The Learning  Partnership